Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) (CAT#: BSDB-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) is designed to be expressed as two polypeptide chains respectively. The two chains are cross-over pairing to form a dimer. It contains a His-tag for affinity purification. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Diabody) (BSDB-132). Click the button below to contact us or submit your feedback about this product.